NanoMaterials
Dr. Qun “Treen” Huo (UCF) – Dr. Huo is a Professor at the University of Central Florida with joint appointments in the NanoScience Technology Center, the Department of Chemistry Department of Mechanics, Materials and Aerospace Engineering, and the Burnett School of Biomedical Sciences. She is the president of Nano Discovery Inc. and Her research focus is on the development and use of gold nanoparticles for biomedical and bioanalytical applications. Treen received her Ph.D. in Chemistry from the University of Miami, Coral Gables, in 1999. She received her Masters of Science in Chemistry at the Sun Yat-sen University in the P.R. China and her Bachelors of Science in Polymer Science, from the University of Science and Technology, also in the P.R. China. She has published over 77 peer-reviewed journal articles, holds 7 patents, and has reviewed and contributed to 8 book chapters. Her research has been funded by NSF, The Florida Department of Health, the UCF. She was awarded the NSF CAREER award in 2003, for her work on gold nanoparticles with single surface functional groups: Synthesis and Study. Additionally, she was awarded the NSF NIRT award in 2005 for her work on total chemical synthesis, property and modeling studies of nanoparticle/polymer hybrid materials.
NanoScience Technology Center
|
NanoChemistry

Dr. Shyam Mohaptra (USF) – Shyam (Sam) S. Mohapatra, PhD, MBA has had a distinguished career in academia in research, teaching, and service at the University of South Florida for that last 26 years. Having completed post-doctoral training in Germany, Canada, and Italy, he settled at USF in 1996 in the College of Medicine, Department of Internal Medicine. Dr. Mohapatra’s research has been extramurally funded by NIH, NSF, Veteran Affairs, U.S. Department of Defense, and the Florida Department of Health. He has published over 243 papers and holds over 40 U.S. and foreign patents. He is recognized for his many inventions in the field of nanoscale biomedical diagnostics and therapeutics in cancers, asthma, viral infections, and traumatic brain injury. In cancers, his inventions and co-inventions have led to several technology platforms and products for innovative anti-cancer drug discovery, drug development, and personalized cancer treatment. His research has spawned inventions that have spun-out companies. Dr. Mohapatra serving as co-founder of Transgenex Nanobiotech, Inc., a USF spin-out company that focuses on commercializing nanoscale innovations and Agile Diagnostics, Inc. that focuses on COVID-19 solutions. He is a Charter Fellow of the National Academy of Inventors (NAI); a fellow of the American Academy of Allergy, Asthma & Immunology (AAAAI); American Institute for Medical and Biological Engineers (AIMBE); and American Association of Advancement of Science (AAAS); and is one of the 2014 inaugural inductees of the Florida Inventors Hall of Fame. Since 2014, he has served as Associate Dean of Graduate Programs at the USF Health Taneja College of Pharmacy and established a highly innovative Master of Science program in Pharmaceutical Nanotechnology with additional concentrations in Drug Discovery and Development and Biomedical Engineering and currently serves as the Faculty Advisor for the student organization, NANO (New Advances in Nanotechnology Organization) since 2017. He cofounded a non-profit organization, Florida Association for Nanobiotechnology (>500 members), which encompasses all academic and industry institutions in the State of Florida engaged in research and education of nanobiotechnology. He currently serves as the President of this organization. |